The other advertising channels, and what each one asks for

Certification unlocks the platform approvals. It does not unlock the platforms. Each channel a telehealth brand uses applies its own policy on top, those policies are not the same, and a growth plan built on the assumption that one credential opens all of them ends in a quarter with one working channel.

Here is the shape of the landscape, and what to prepare for each.

Paid search

The most documented path and the one with the clearest gate. The platform healthcare approval is a separate application, filed at the advertising account level, referencing your public certification listing.

Everything about sequencing here is covered in the second application nobody plans for, and the single most common failure is worth restating: the domain in the ad has to be the domain in the listing.

Paid social

Different in kind rather than in degree. The gate is less often a formal healthcare certification and more often a policy review of the creative and the landing page, applied by systems that act quickly and explain little.

What that changes in practice:

• Creative is the surface. A compliant landing page behind a before-and-after image is still a rejection, and the image is the part reviewed first.
• Personal attributes rules bite. Copy addressing the viewer as though their health status is known is restricted on the major social platforms independently of anything else.
• Rejections are automated and terse. Build a creative library that is compliant by default rather than appealing case by case.

Native and programmatic

The channel where the claims problem is hardest to control, because the copy that converts is advertorial and advertorials make claims for a living.

Two rules keep this survivable. First, the advertorial is your marketing surface whether you wrote it or the network did, so it goes through the same claims approval as your own pages. Second, whatever the advertorial says has to be true of the page it lands on, because a reviewer of either the platform or the certification kind reads them together.

Affiliate and publisher traffic

Screened on the credential before the conversation opens, and then governed by what your publishers write, which is a separate discipline covered in affiliate networks and the credential they screen on.

The point worth carrying here is that this channel imports risk into the others. A publisher page comparing your compounded preparation to a brand-name drug is reachable by every platform reviewer looking at your account.

Email and SMS

The channel teams forget entirely when they think about compliance, and the one with the longest tail.

Sequences written eighteen months ago by somebody who has left are still sending. The abandoned-cart flow, the win-back, the dosing reminder and the referral prompt all describe the product, and they describe it in the voice the brand had before anybody wrote a claims allowlist.

They are also discoverable: an old sequence reaches the reviewer's inbox exactly as easily as a customer's. Audit them with the same list you use for landing pages, and put a review step in front of new ones.

Marketplaces, comparison sites and app stores

Each carries its own healthcare listing rules, and each publishes a description of your product written partly by you and partly by them. App store listings in particular are a claims surface with screenshots, and screenshots are where outcome claims hide.

The plan that survives a policy change

Platform policy in the medicines categories moves, and it moves in one direction: whatever the enforcement attention is on tightens. Our index of FDA warning letters over compounded GLP-1 marketing is a fair proxy for where that attention sits: it codes every letter by what it cites, and misbranding and comparisons to the brand-name product are what the series turns on.

So the resilient position is not a clever reading of current policy. It is an account built on claims that would survive the strictest reviewer of the set: a named prescriber, an honest description of what the preparation is, service rather than outcome as the differentiator, and no comparison to an approved product anywhere.

Accounts built that way lose a little performance on paper and keep serving through policy sweeps. Accounts built on the generous interpretation stop overnight, and a suspension takes the account history with it rather than pausing it.

What to do when a channel closes

It will happen, and the response in the first hour decides how much it costs.

Read the notice literally. Platform decline and suspension notices are terse but usually accurate about which policy was applied. The instinct to interpret them as arbitrary wastes the one piece of information you were given.

Do not soften one page and leave the claim elsewhere. Policy sweeps read the domain rather than the page you edited, and a partial fix invites the same enforcement with a worse history attached.

Check the listing first if the notice mentions certification. The most common cause is a domain mismatch between the ad and the listing rather than anything about the copy.

Do not rebuild the account under a new identity. Circumventing an enforcement action is a separate and far more serious violation than whatever closed the account, and it converts a recoverable problem into a permanent one.

Assume the other channels will follow. A claim that closed one channel is on the same pages the others read, so treat a single suspension as a site-wide audit trigger rather than as a channel problem.

What to hold centrally

One creative approval process for every channel, one allowlist, one person who reads new copy, and one register of which channels are approved, under what, and when each was last reviewed. Five channels with five separate compliance practices is how a brand ends up with the same forbidden sentence live in three of them.